Clinical Trials Logo

Clinical Trial Summary

Congenital hearing loss, as well as hearing loss present at birth, is one of the most common chronic conditions in children, with a prevalence of permanent bilateral hearing loss of 2.83 per 1000 children of primary school age, which is mainly caused by genetic factors. The goal of this observational study is to learn about novel causative genes in infants with hearing loss in the Chinese population. The main problem it aims to deal with are: - to present the genetic characteristics of the infant with hearing loss in the Chinese population - to build up a prognostic model base on diverse data. Participants will be asked to receive audiological tests and collection of the peripheral blood sample.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06365749
Study type Observational
Source Tongji Hospital
Contact
Status Not yet recruiting
Phase
Start date April 23, 2024
Completion date November 23, 2026

See also
  Status Clinical Trial Phase
Completed NCT00400413 - Neuroanatomy of Reading in Congenital Deafness. N/A
Recruiting NCT05402813 - Natural History in Children up to 10 Years With Moderate to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes
Completed NCT03319524 - Clinical and Genetic Testing of Patients With Usher Syndrome
Completed NCT00106743 - Natural History and Genetic Studies of Usher Syndrome
Terminated NCT03866850 - Degenerative Consequences of Congenital Deafness
Not yet recruiting NCT06370351 - A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations Phase 1/Phase 2
Not yet recruiting NCT04350619 - NGS Assessment of Congenitally Deafned Children and Neonatal Deafness Screnning